Hussein Awada

509 total citations
41 papers, 223 citations indexed

About

Hussein Awada is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Hussein Awada has authored 41 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 17 papers in Genetics and 10 papers in Oncology. Recurrent topics in Hussein Awada's work include Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Multiple Myeloma Research and Treatments (7 papers). Hussein Awada is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Multiple Myeloma Research and Treatments (7 papers). Hussein Awada collaborates with scholars based in United States, Italy and France. Hussein Awada's co-authors include Carmelo Gurnari, Hassan Awada, Valeria Visconte, Adel Hajj Ali, Assaad A. Eid, Hasan Nassereldine, Gianfranco Pintus, Jaroslaw P. Maciejewski, Elias Baydoun and Fouad A. Zouein and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Leukemia.

In The Last Decade

Hussein Awada

37 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hussein Awada United States 9 99 87 64 39 38 41 223
Ajoy Dias United States 9 71 0.7× 41 0.5× 57 0.9× 50 1.3× 33 0.9× 27 216
Miltiadis Gerolymos Greece 8 62 0.6× 50 0.6× 148 2.3× 25 0.6× 30 0.8× 11 333
Kian Meng Chang Malaysia 8 100 1.0× 33 0.4× 28 0.4× 71 1.8× 19 0.5× 29 198
Ali Abdulnabi Suwaidan United Kingdom 8 36 0.4× 43 0.5× 118 1.8× 47 1.2× 42 1.1× 13 234
Lucía López‐Anglada Spain 9 158 1.6× 49 0.6× 64 1.0× 75 1.9× 9 0.2× 14 245
Tobias Terzer Germany 7 105 1.1× 112 1.3× 55 0.9× 49 1.3× 8 0.2× 13 295
Daniela Piccioni Italy 8 75 0.8× 92 1.1× 64 1.0× 47 1.2× 11 0.3× 22 221
Nádia Correia Portugal 7 38 0.4× 137 1.6× 35 0.5× 17 0.4× 83 2.2× 9 227
Craig D. Seaman United States 10 232 2.3× 65 0.7× 33 0.5× 85 2.2× 10 0.3× 24 355
Michael J. Martens United States 9 126 1.3× 30 0.3× 44 0.7× 18 0.5× 9 0.2× 30 193

Countries citing papers authored by Hussein Awada

Since Specialization
Citations

This map shows the geographic impact of Hussein Awada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein Awada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein Awada more than expected).

Fields of papers citing papers by Hussein Awada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein Awada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein Awada. The network helps show where Hussein Awada may publish in the future.

Co-authorship network of co-authors of Hussein Awada

This figure shows the co-authorship network connecting the top 25 collaborators of Hussein Awada. A scholar is included among the top collaborators of Hussein Awada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hussein Awada. Hussein Awada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurnari, Carmelo, Carlos Bravo‐Pérez, Arda Durmaz, et al.. (2025). Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia. Leukemia. 39(3). 748–751. 3 indexed citations
2.
Fattizzo, Bruno, Carmelo Gurnari, Sabrina Giammarco, et al.. (2025). Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World. American Journal of Hematology. 100(4). 584–591. 3 indexed citations
3.
Heinken, Almut, Hussein Awada, Vito Riccardo Tomaso Zanotelli, et al.. (2025). Personalized Genome‐Scale Modeling Reveals Metabolic Perturbations in Fibroblasts of Methylmalonic Aciduria Patients. Journal of Inherited Metabolic Disease. 48(5). e70077–e70077. 1 indexed citations
4.
Lin, Chien‐Chin, Carmelo Gurnari, Hussein Awada, et al.. (2025). Redefining the myeloid disease continuum: Machine learning–based development and validation of an integrated multimodal classification of myeloid neoplasms. Blood. 146(Supplement 1). 4347–4347.
5.
Gurnari, Carmelo, Hussein Awada, Simona Pagliuca, et al.. (2024). Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis. Blood. 144(2). 145–155. 6 indexed citations
6.
Awada, Hussein, Carmelo Gurnari, Valeria Visconte, et al.. (2024). Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders. Leukemia. 38(6). 1266–1274. 5 indexed citations
7.
Dima, Danai, Al‐Ola Abdallah, James A. Davis, et al.. (2024). Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy. Blood Cancer Journal. 14(1). 90–90. 11 indexed citations
8.
Kewan, Tariq, Arda Durmaz, Waled Bahaj, et al.. (2024). Clinical and Molecular Insights into the Classification Dilemma: Are MDS/AML Cases Distinct from Secondary AML?. Blood. 144(Supplement 1). 850–850. 1 indexed citations
9.
Awada, Hussein, Arda Durmaz, Tariq Kewan, et al.. (2024). Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis. Leukemia. 38(6). 1411–1414.
10.
Piciocchi, Alfonso, Tiziana Ottone, Emiliano Fabiani, et al.. (2023). Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting. Blood Advances. 7(17). 5122–5131. 11 indexed citations
11.
Fattizzo, Bruno, Carmelo Gurnari, Hussein Awada, et al.. (2023). Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study. Leukemia. 37(12). 2479–2485. 5 indexed citations
12.
Awada, Hussein, et al.. (2023). Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management. Cleveland Clinic Journal of Medicine. 90(5). 307–317. 7 indexed citations
13.
Awada, Hussein, Carmelo Gurnari, Zhuoer Xie, Jan Philipp Bewersdorf, & Amer M. Zeidan. (2023). What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach. Cancers. 15(8). 2248–2248. 5 indexed citations
14.
Bahaj, Waled, Tariq Kewan, Carmelo Gurnari, et al.. (2023). Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia. Journal of Hematology & Oncology. 16(1). 91–91. 14 indexed citations
15.
Awada, Hussein, et al.. (2023). High-grade large cell neuroendocrine carcinoma of the esophagus: a case report and review of the literature. Journal of Medical Case Reports. 17(1). 144–144. 2 indexed citations
16.
Awada, Hussein, Carmelo Gurnari, Arda Durmaz, et al.. (2022). Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes. International Journal of Molecular Sciences. 23(5). 2802–2802. 10 indexed citations
17.
Nassereldine, Hasan, Hussein Awada, Adel Hajj Ali, et al.. (2022). Pancreatic cancer in the MENA region, a bibliometric review. ecancermedicalscience. 16. 1380–1380. 9 indexed citations
18.
Nassereldine, Hasan, Razan Mohty, Hussein Awada, et al.. (2022). Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report. Journal of Medical Case Reports. 16(1). 254–254. 2 indexed citations
19.
Awada, Hussein, et al.. (2020). Knowledge, attitudes, and practices regarding drug interactions among community pharmacists. Journal of Public Health. 29(6). 1357–1363. 12 indexed citations
20.
Awada, Hussein, Ahmed F. El‐Yazbi, Fouad A. Zouein, et al.. (2019). MicroRNAs as Potential Pharmaco-Targets in Ischemia-Reperfusion Injury Compounded by Diabetes. Cells. 8(2). 152–152. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ajoy Dias Breakdown of academic impact, for papers by Miltiadis Gerolymos Breakdown of academic impact, for papers by Kian Meng Chang Breakdown of academic impact, for papers by Ali Abdulnabi Suwaidan Breakdown of academic impact, for papers by Lucía López‐Anglada Breakdown of academic impact, for papers by Tobias Terzer Breakdown of academic impact, for papers by Daniela Piccioni Breakdown of academic impact, for papers by Nádia Correia Breakdown of academic impact, for papers by Craig D. Seaman Breakdown of academic impact, for papers by Michael J. Martens
Rankless by CCL
2026